| Literature DB >> 28465495 |
Peng Lin1,2, Youyou Shao3, Huigen Lu1,4, Zhengliang Zhang1,5, Haiqing Lin1,4, Shengdong Wang1, Binghao Li1, Hengyuan Li1, Zhan Wang1, Nong Lin1, Zhaoming Ye1.
Abstract
The mechanical outcomes of patients with pelvic bone tumors involving zone I or zone I + IV who received resection and different reconstructions are not clear. Therefore, the purpose of this study was to compare the outcomes of different rod-screw systems in reconstruction for these patients, and evaluate the relative risk of mechanical failure for them. We reviewed 30 patients for a mean duration of 40.4 months of follow-up (range, 13.1-162.2 months), five patients had mechanical complications. The mechanical survival rate of two-rod and four-screw (TRFS) group was significantly higher than one-rod and two-screw (ORTS) group (p = 0.000). The implant survival rate was correlated with ages (p = 0.010), younger people are more likely to fail. Thus, TRFS fixation for pelvic reconstruction after Enneking type I/I + IV resection can provide better short to long-term mechanical stability compared with ORTS fixation, the strength of ORTS fixation is not enough. In addition, biological reconstruction such as autologous bone graft is recommended for the patients who are younger or suffered from benign tumor. As for the patients who are older, with malignant tumors, underwent adjuvant radiotherapy or chemotherapy, functional reconstruction with bone cement is a good choice.Entities:
Keywords: Enneking type I/I + IV; limb salvage surgery; mechanical failure; pelvic girdle reconstruction; pelvic tumor
Mesh:
Year: 2017 PMID: 28465495 PMCID: PMC5503588 DOI: 10.18632/oncotarget.17164
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1A 16-year-old female (case 4) with diagnosis of pelvis osteosarcoma affecting zone I + IV
(A) AP radiograph at one week post-operatively. (B) AP radiograph at 61.9 months post-operatively, showing failure of the implant, and the implant was stabbed to the skin when she stooped, (C) AP radiograph after the construction was revised and augmented with an autologous fibular graft 80 months post-operatively.
Figure 2A 20-year-old male (case 25) with diagnosis of pelvis osteosarcoma affecting zone I
(A) AP radiograph at two weeks post-operatively. (B) AP radiograph at 30.5 months post-operatively, showing failure of the implant and with functional impairment. (C) AP radiograph at one week after removal of the implant.
Figure 3A 37-year-old female (case 26) with diagnosis of pelvis chondrosarcoma affecting zone I
(A) AP radiograph of the pelvis after bone tumor resection and reconstruction with an autograft bone and screw-rod system. (B) AP radiograph showing the implant loosening 3 months post-operatively without functional impairment. (C) at 51.3 months post-operatively, AP radiograph showing failure of the implant, pseudoarthrosis formation was found in the resection site, and degeneration was developed in the symphysis pubis.
Figure 4A 15-year-old female (case 28) with diagnosis of pelvis osteosarcoma affecting zone I
(A) AP radiograph of the pelvis after bone tumor resection and reconstruction with screw-rod system and bone cement. (B) AP radiograph showing the implant loosening 14 months post-operatively without functional impairment.
Figure 5Overall implant survival analysis through Kaplan-Meier for different reconstruction method
Number of patients: 30 patients. A statistically significant difference was noted between the one-rod two-screw group and the two-rod four-screw group (p = 0.000).
Patient demographics data and adjuvant therapy details
| No. | Age | Gender | Height (cm) | Weight (kg) | BMI | Histologic diagnosis | Bone graft | Bone cement | Chemotherapy | Radiotherapy |
|---|---|---|---|---|---|---|---|---|---|---|
| 26 | Female | 158 | 40.5 | 16.2 | Osteoclastoma | None | Yes | None | None | |
| 35 | Male | 174 | 70 | 23.1 | Osteoclastoma | Yes | None | None | None | |
| 48 | Female | 158 | 53 | 21.2 | Non-ossifying fibroma | Yes | None | None | None | |
| 16 | Female | 150 | 34 | 15.1 | Osteosarcoma | None | Yes | Yes | None | |
| 41 | Male | 175 | 65 | 21.2 | Chondrosarcoma | Yes | None | None | None | |
| 44 | Female | 162 | 49 | 18.7 | Osteoclastoma | Yes | None | None | None | |
| 39 | Male | 168 | 60 | 21.3 | Chondrosarcoma | Yes | None | None | None | |
| 63 | Female | 149 | 52 | 23.4 | Chondrosarcoma | Yes | None | None | None | |
| 33 | Male | 173 | 65 | 21.7 | Chondrosarcoma | None | Yes | None | None | |
| 59 | Male | 174 | 53 | 17.5 | Osteosarcoma | None | Yes | Yes | None | |
| 38 | Male | 165 | 55 | 20.2 | Benign | Yes | None | None | None | |
| 68 | Male | 177 | 63 | 20.1 | Chondrosarcoma | None | Yes | None | None | |
| 43 | Female | 161 | 61 | 23.5 | Osteosarcoma | Yes | None | Yes | None | |
| 48 | Female | 164 | 47 | 17.5 | Metastatic Thyroid cancer | None | Yes | None | Yes | |
| 66 | Male | 172 | 58 | 19.6 | Metastatic bladder cancer | None | Yes | None | None | |
| 36 | Female | 164 | 55 | 20.4 | Osteoclastoma | None | Yes | None | None | |
| 69 | Female | 167 | 55 | 19.7 | Metastatic cancer | None | Yes | Yes | None | |
| 15 | Male | 165 | 35 | 12.9 | Chondrosarcoma | Yes | None | Yes | None | |
| 59 | Female | 164 | 48 | 17.8 | Osteosarcoma | None | None | Yes | None | |
| 28 | Male | 174 | 52 | 17.2 | Chondrosarcoma | Yes | None | None | None | |
| 44 | Female | 165 | 55 | 20.2 | Malignant fibrous histiocytoma | None | None | Yes | None | |
| 19 | Male | 172 | 60 | 20.3 | Fibrosarcoma | None | None | None | None | |
| 34 | Male | 172 | 55 | 18.6 | Solitary fibrous tumor | Yes | None | None | None | |
| 24 | Male | 173 | 56 | 18.7 | Ewing's sarcoma | Yes | None | Yes | Yes | |
| 20 | Male | 172 | 64 | 21.6 | Osteosarcoma | None | None | Yes | None | |
| 37 | Female | 165 | 60 | 22.0 | Chondrosarcoma | Yes | None | None | None | |
| 32 | Female | 161 | 50 | 19.3 | Chondrosarcoma | Yes | None | None | None | |
| 15 | Female | 159 | 50 | 19.8 | Osteosarcoma | None | Yes | Yes | Yes | |
| 61 | Male | 165 | 55 | 20.2 | Aneurysmal bone cyst | None | Yes | None | None | |
| 62 | Male | 174 | 58 | 19.2 | Metastatic malignant melanoma | None | None | Yes | None |
Surgical details, complications and the outcomes of the patients
| No. | Type of resection | Site of fixation (proximal/distal) | Method of fixation | Type of fixation | MSTS score (%) | Complications | mechanical survival time (months) | Mechanical outcome | Follow-up period (months) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | I | Vertebral pedicle (L5), sacrum/ periacetabular bone | 2 rods 4 screws | EXP + INP | 97 | 162.2 | AMF | 162.2 | |
| 2 | I | Transverse process (L5), sacrum/ periacetabular bone | 2 rods 4 screws | EXP + INP | 90 | 107.1 | AMF | 107.1 | |
| 3 | I | Transverse process (L5, sacrum)/periacetabular bone | 2 rods 4 screws | EXP + INP | 90 | 106.2 | AMF | 106.2 | |
| 4 | I + IV | Transverse process (L5), sacrum/ periacetabular bone | 2 rods 4 screws | EXP + INP | 77 | Neurological defects, metal breakage | 61.9 | MF | 84.5 |
| 5 | I | Transverse process (L5), sacrum/periacetabular bone | 2 rods 4 screws | EXP + INP | 87 | Bone nonunion | 65.8 | DMF | 65.8 |
| 6 | I | Transverse process sacrum/ periacetabular bone | 2 rods 4 screws | INP + INP | 97 | 54.4 | AMF | 54.4 | |
| 7 | I | Transverse process sacrum/ periacetabular bone | 2 rods 4 screws | INP + INP | 87 | Superficial infection | 35.2 | DMF | 35.2 |
| 8 | I | Vertebral pedicle (L5), sacrum/ periacetabular bone | 2 rods 4 screws | INP+EXP | 87 | 33.5 | AMF | 33.5 | |
| 9 | I | Transverse process (L5), sacrum/ periacetabular bone | 2 rods 4 screws | INP+EXP | 83 | 27.0 | DMF | 27.0 | |
| 10 | I | Transverse process (L5), sacrum/ periacetabular bone | 2 rods 4 screws | EXP + INP | 83 | Wound complication | 26.1 | DMF | 26.1 |
| 11 | I | Transverse process sacrum/ periacetabular bone | 2 rods 4 screws | INP + INP | 93.3 | 25.3 | AMF | 25.3 | |
| 12 | I | Transverse process sacrum/ periacetabular bone | 2 rods 4 screws | INP + INP | 87 | 24.3 | DMF | 24.3 | |
| 13 | I | Transverse process (L5), sacrum/ periacetabular bone | 2 rods 4 screws | EXP + INP | 90 | 23.1 | DMF | 23.1 | |
| 14 | I | Transverse process sacrum/ periacetabular bone | 2 rods 4 screws | INP + INP | 63.3 | 21.1 | DMF | 21.1 | |
| 15 | I | Transverse process sacrum/periacetabular bone | 2 rods 4 screws | INP + INP | 80 | Wound complication | 14.5 | AMF | 14.5 |
| 16 | I | Transverse process (L5),sacrum/periacetabular bone | 2 rods 4 screws | EXP + INP | 90 | 14.2 | AMF | 14.2 | |
| 17 | I | Transverse process sacrum/ periacetabular bone | 2 rods 4 screws | INP + INP | 77 | 14.2 | DMF | 14.2 | |
| 18 | I | Vertebral pedicle (L5), sacrum/ periacetabular bone | 2 rods 4 screws | EXP + INP | 97 | 13.1 | AMF | 13.1 | |
| 19 | I + IV | Vertebral pedicle (L5, S1)/ periacetabular bone | 1 rod 4 screws | EXP + EXP | 67 | Neurological defects, deep venous thrombosis | 19.1 | AMF | 19.1 |
| 20 | I | Vertebral pedicle (L5, S1)/ periacetabular bone | 1 rod 4 screws | EXP + EXP | 90 | 18.7 | DMF | 18.7 | |
| 21 | I + IV | Vertebral pedicle (L4, 5) / periacetabular bone | 1 rod 4 screws | EXP + EXP | 60 | Neurological defects | 13.4 | DMF | 13.4 |
| 22 | I + IV | Vertebral pedicle (L4, 5)/ periacetabular bone | 1 rod 3 screws | EXP | 60 | Neurological defects, implant loosening | 20.7 | MF | 41.0 |
| 23 | I + IV | Transverse process (L5)/ periacetabular bone | 1 rod 3 screws | EXP | 83 | 19.6 | AMF | 19.6 | |
| 24 | I | Vertebral pedicle (L5, S1)/ periacetabular bone | 1 rod 3 screws | INP | 87 | 14.4 | AMF | 14.4 | |
| 25 | I + IV | vertebral pedicle (L4)/periacetabular bone | 1 rod 2 screws | EXP | 43 | Implant loosening | 30.5 | MF | 67.3 |
| 26 | I | Transverse process sacrum/ periacetabular bone | 1 rod 2 screws | INP | 50 | Metal breakage | 3.0 | MF | 67.2 |
| 27 | I | Transverse process sacrum/ periacetabular bone | 1 rod 2 screws | INP | 90 | 41.1 | AMF | 41.1 | |
| 28 | I | Transverse process sacrum/ periacetabular bone | 1 rod 2 screws | INP | 67 | Implant loosening | 14.0 | MF | 32.1 |
| 29 | I | Transverse process sacrum/periacetabular bone | 1 rod 2 screws | INP | 91 | 13.7 | AMF | 13.7 | |
| 30 | I | Vertebral pedicle (L5)/ periacetabular bone | 1 rod 2 screws | EXP | 87 | Wound complication | 13.2 | DMF | 13.2 |
INP: intrapelvic, sacral-pelvic reconstruction, EXP: extrapelvic, lumbo-pelvic reconstruction, MSTS: Musculoskeletal Tumor Society, AMF: alive with no mechanical failure, DMF: died with no mechanical failure, MF: mechanical failure.
Potential risk factors of post-operative implant failures in univariate analysis
| Variables | Mechanical failure No. (%) | Non-mechanical failure No. (%) | |
|---|---|---|---|
| Rod-screw system | 0.000* | ||
| One-rod two-screw (ORTS) | 4 (44.4) | 5 (55.6) | 0.008* |
| EXP | 2 (50) | 2 (50) | 0.910# |
| INP | 2 (40) | 3 (60) | |
| Two-rod four-screw (TRFS) | 1 (4.8) | 20 (95.2) | |
| EXP + EXP | 0 (0) | 3 (100) | |
| INP + EXP | 1 (9.1) | 10 (90.9) | 0.001## |
| INP + INP | 0 (0) | 7 (100) | 0.034## |
| Tumor location | 0.022 | ||
| I | 2 (8.3) | 22 (91.7) | |
| I + IV | 3 (50) | 3 (50) | |
| Reconstruction | 0.054 | ||
| Bone graft | 1 (7.1) | 13 (92.9) | 0.033### |
| Bone cement | 2 (18.2) | 9 (81.8) | 0.122### |
| None | 2 (40) | 3 (60) | |
| Chemotherapy | 0.085 | ||
| Yes | 3 (27.3) | 8 (72.7) | |
| None | 2 (10.5) | 17 (89.5) | |
| Radiotherapy | 0.150 | ||
| Yes | 1 (33.3) | 2 (66.7) | |
| None | 4 (14.8) | 23 (85.2) | |
| Gender | 0.730 | ||
| Male | 2 (12.5) | 14 (87.5) | |
| Female | 3 (21.4) | 11 (78.6) | |
| Age (years) | 0.000 | ||
| < 22 | 4 (80) | 1 (20) | |
| > 22 | 1 (4) | 24 (96) | |
| BMI | 0.317 | ||
| < 19.75 | 1 (7.1) | 13 (92.9) | |
| > 19.75 | 4 (25) | 12 (75) | |
| All | 5 (16.7) | 25 (83.3) |
Significant at a = 0.05 *significant difference between ORTS and TRFS group, *significant difference between five sub groups by the pooled over strata test, #compared with INP group by pairwise for each stratum test, ##compared with EXP group by pairwise for each stratum test, ###compared with None group by pairwise for each stratum test. (Kaplan-Meier survival analysis, Log rank test was used to compare implant survival rates between different groups). INP: intrapelvic, sacral-pelvic reconstruction, EXP: extrapelvic, lumbo-pelvic reconstruction.
Figure 6A 32-year-old woman (case 27) with diagnosis of pelvis chondrosarcoma affecting zone I
(A) AP radiograph of the pelvis after internal hemipelvectomy and subsequent pelvic ring reconstruction with screw-rod system and autograft bone. (B) AP radiograph showing the bone union 12.3 months post-operatively.
Figure 7A 26-year-old female (case 1) with diagnosis of pelvis osteoclastoma affecting zone I
(A) AP radiograph of the pelvis shows internal hemipelvectomy and subsequent pelvic ring reconstruction with screw-rod system and bone cement. (B, C) CT images show no evidence of tumor recurrence or implant loosening 144.1 months post-operatively.
Figure 8A 44-year-old woman (case 6) with diagnosis of pelvis osteoclastoma affecting zone I
(A) AP radiograph of the pelvis after bone tumor resection and reconstruction with an autograft bone in the pelvis stabilized with the implantation of screw-rod system. (B) Coronal CT image showing the bone union 17.5 months post-operatively. (C) AP radiograph of the pelvis shows no evidence of tumor recurrence or implant loosening 36 months post-operatively.